ADMA vs STE · P/E 22, rev $426.5M vs P/E 25, rev $5.46B
ADMA Biologics Inc (ADMA) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the ADMA and STE stock pages for the full models.
Not investment advice.